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Autographa califomica multicapsid nuclear polyhedrosis virus-infected insect cells express a viral immediate-
early transcriptional regulatory protein, IEl, that has been shown by transient-expression assays to stimulate
the expression of certain baculovirus delayed-early (DE) promoters and to inhibit the expression of other
immediate-early (IE) genes. It is believed that certain DE promoters are activated, in part, by direct
interactions between IEl and enhancer elements located in regions adjacent to these genes. We have used
transient cotransfection and DNA-binding assays to examine the function of mutant forms of IEl. Our results
indirectly show that IEl has at least two separable domains that are essential for its role in the modulation of
baculovirus gene expression. A domain rich in acidic residues and essential for transactivation is located within
the N-terminal 145 amino acids of the polypeptide. A second domain, located in the C-terminal 437 amino acids
of IE1, is required for inhibitory and DNA-binding activities. Several nontransactivating TEl mutants
trans-dominantly interfered with wild-type IEl transactivation of enhancer-linked DE genes. trans-dominant
interference was expressed only by IE1 mutants that retained the N-terminal putative acidic activation domain,
suggesting that this region may be involved in associations with a factor(s) essential for activation of
enhancer-linked genes.
Viruses have served as model systems for studies of gene
expression and regulation in both prokaryotic and eukary-
otic cellular systems. Viral gene expression is tightly regu-
lated by interactions between viral and host cell factors.
Most viruses express their genes in temporally ordered tiers
that can be classified according to their kinetics of expres-
sion, dependence on viral DNA replication, and requirement
for the prior expression of one or more viral regulatory
factors. Baculovirus genes have been grouped into three
temporal classes: early (E), late (L), and very late (VL; for a
review, see reference 1). E genes are distinguished from L
and VL genes in that their expression is independent of viral
DNA replication. Additionally, E genes are transcribed by an
a-amanitin-sensitive RNA polymerase II activity, whereas L
and VL transcription is controlled by a virus-encoded/regu-
lated cx-amanitin-insensitive activity (22). E genes have been
further divided into two subgroups (immediate-early [IE] genes
and delayed-early [DE] genes) on the basis of transient-expres-
sion (3, 16, 29) and cycloheximide blockage (25, 35) experi-
ments. IE promoters are fully active in the absence of other
viral factors. DE promoters require one or more IE gene
products foj*full activation (3, 10, 16, 25, 35, 36), although some
low-level expression may be detected in the absence of viral
transactivators (41). From several studies, it is believed that
IE gene products function as viral gene regulators (3-5, 16,
18, 29, 30, 41) and that some DE factors control viral DNA
replication (32, 37, 42). L and VL genes encode structural
proteins involved in viral encapsidation and polyhedron
assembly. In sum, the entire baculovirus life cycle is be-
lieved to be initiated, in part, by IE gene products; a
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knowledge of the how these gene products function is central
to the understanding of the biology of baculoviruses and the
processes involved in the regulation of insect genes.
The IE1 gene of Autographa californica multicapsid nu-
clear polyhedrosis virus (AcMNPV) has been shown, on the
basis of transient-expression experiments, to encode a mul-
tifunctional regulatory protein (4, 17, 29). IE1 is transcribed
from a single promoter throughout infection as an unspliced
1.9-kb RNA with an open reading frame (ORF) encoding a
70-kDa protein. A slightly longer form of IE1 (spliced-IEl or
IEO [6]) is transcribed early and late from two different start
sites located approximately 4 kbp upstream of the IE1
promoter (28). Studies have shown that IE1 induces the
expression of several chimeric genes linked to DE (16, 17)
and L (19) gene promoters, an activity termed enhancer
independent. Two independent studies have also demon-
strated that the IE1 gene product of both AcMNPV (29) and
Orgia pseudotsugata multicapsid nuclear polyhedrosis vi-
rus (OpMNPV [41]) has autoregulatory properties; i.e., it
stimulates its own expression. IE1 not only transactivates
promoters but also increases the transcription rate of several
baculovirus and heterologous promoters cis-linked to homol-
ogous region (hr) enhancers, an activity termed enhancer
dependent (17). Insect cells transfected with IE1 contain an
enhancer-specific DNA-binding activity (14), leading us to
believe that enhancer-dependent transactivation may be
mediated by a direct interaction between the IE1 gene
product and the viral enhancers. Lastly, IE1 not only
stimulates gene expression but also inhibits the expression of
chimeric genes linked to the IEO (29) and IEN (4) promoters.
On the basis of its demonstrated activities in both tran-
sient-expression and DNA-binding assays, it was reasonable
for us to hypothesize that the IE1 gene product, like other
trans-acting factors, may contain genetically separable au-
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tonomous domains. Therefore, we constructed a number of
N- and C-terminal IEl deletion mutants and analyzed them
by transient-expression and DNA-binding assays. Our re-
sults demonstrate that IE1 is a complex protein with at least
two distinct regions: an N-terminal putative acidic activation
domain, and a C-terminal region that is required for inhibi-
tion of IEO and DNA binding. Our results also show that
several nontransactivating forms of IE1 abrogate the ability
of wild-type IE1 to transactivate an hr-linked gene; i.e., they
act as trans-dominant repressors.
MATERIALS AND METHODS
Cell culture. Spodoptera frugiperda (Sf9) cells were pas-
saged in spinner flasks at 27°C as previously described (40).
Plasmid constructions. A schematic representation of all
IE1 plasmids used in this study is shown in Fig. 1A. All
recombinant plasmids were constructed in vitro by standard
cloning techniques (34) and sequenced (39). The wild-type
IEl plasmid (pNheIEl) was derived from pIE1 (16) by
digestion with NheI and SmaI, repair of the 5' extensions
with the large fragment of DNA polymerase I, and subse-
quent religation. IEl C-terminal deletion mutants were con-
structed by inserting a synthetic deoxyoligonucleotide linker
(pCTAGCTAGCTAG), encoding nonsense codons in all
three reading frames, into convenient restriction sites within
the IEl ORF. N-terminal mutants were derived from an
IEl-encoding plasmid (29) that contains a unique BamHI
restriction endonuclease site immediately 3' to the transla-
tion initiation codon (ATGGATCC; ATG in bold, BamHI
site underlined). Subsequently, this plasmid was digested
with BamHI and either AvaI, EcoRV, or DraIII to yield the
mutants A2-16, A2-52, and A2-145, respectively. 5' exten-
sions derived from DNAs digested with BamHI and either
Aval or EcoRV were repaired with Klenow polymerase, and
a synthetic 10-mer BglII linker (pGAAGATCTTC) was
inserted to maintain the proper reading frame. DNA digested
with BamHI and DraIII was blunt ended with T4 polymerase
and subsequently religated.
The IE0/IE1 reporter (pGCAT) used in this study has been
described previously (29). Briefly, it contains the chloram-
phenicol acetyltransferase (CAT) gene cloned 36 bp down-
stream of the IE1 ATG in pH3G (HindITI G fragment of
AcMNPV; 90.6 to 96.8 map units), and expresses IEOCAT
and IElCAT fused gene products. The IE1 nonsense mutant
(pIE1AORF [29]), the DE 39-kDa reporters (39K reporters;
p39CAT and p39CATQ- [17]), and the plasmid IBI-24 (14)
containing the hr5 enhancer have been previously described.
The plasmid GC123 contains the IEO ORF (derived from its
cDNA) cloned under the control of its native promoter; it
was obtained from Dennis Henner and George Chisholm.
CAT assays. Transfections were done by the calcium
phosphate precipitation method (16). Briefly, 106 Sf9 cells
were seeded onto six-well plates and allowed to attach for 1
h. Subsequently, the cells were transfected with plasmids
and pUC DNA as carrier for a total DNA concentration of 10j±g/106 cells. Lysates were prepared 24 h posttransfection
and assayed for CAT expression (12).
Radioimmunoprecipitation assays. Sf9 cells were seeded at
a density of 106 cells per well in six-well plates and trans-
fected with 10 ,ug of DNA per well. Approximately 15 h
posttransfection, cells were incubated for 2 h in methionine-
free Grace's medium. Subsequently, cells were radiolabeled
with 100 ,uCi of [35S]methionine (Amersham) per ml in
methionine-free Grace's medium for 1 h at 27°C. Extracts
were prepared (23) and incubated with either polyclonal
anti-IE1 antiserum at a dilution of 1:500 or polyclonal
anti-CAT antiserum (5'-3') at a 1:250 dilution. Immunopre-
cipitates were collected (26) and analyzed by sodium dode-
cyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
(31) and autoradiography.
Electrophoretic mobility shift assay (EMSA). Sf9 cells were
seeded at a density of 9 x 106 cells per T-75 flask and
transfected with 90 ,ug of DNA. Approximately 24 h post-
transfection, whole-cell extracts were prepared as described
previously (14). A 252-bp fragment containing a portion of
hr5 was derived from pIBI-24 and end labeled with T4
polynucleotide kinase essentially as described previously
(14). Protein-DNA complexes were separated by native gel
electrophoresis and analyzed by autoradiography.
RESULTS
Analysis of the effect ofIEl deletions on DE gene enhancer-
independent and -dependent transactivation. To investigate
the structural elements essential for its activities, we con-
ducted a functional dissection of the IE1 polypeptide. A
series of N- and C-terminal deletion mutants (Fig. 1A) were
constructed and subsequently tested by transient-expression
assays. The wild-type plasmid (pNheIE1) used to construct
deletion mutants contains the entire IE1 ORF, 428 bp of
upstream regulatory sequences, and 640 bp of downstream
sequences. This plasmid does not contain any IEO regulatory
or coding sequences; thus, Sf9 cells transfected with this
plasmid express only unspliced TEl RNA. Mutants were
sequenced to determine deletion end points (Fig. 1B). Some
C-terminal mutants have additional non-IEl-encoded amino
acids at their C termini as a result of the synthetic linker used
to introduce a translation termination signal. N-terminal
mutants retain the native IE1 ATG translation initiation
codon followed by sequences encoded by synthetic oligonu-
cleotides inserted to maintain the proper reading frame.
A transient-expression assay was used to analyze the
transactivation activities of IE1 deletion mutants. In these
assays, wild-type or mutant IE1 and either p39CAT (en-
hancerless) or p39CATQ- (hr5 enhancer-plus) were co-
transfected into Sf9 cells. One day later, cell extracts were
prepared and assayed for CAT activity. The cumulative
results of this assay show that both enhancer-independent
(Fig. 2A) and enhancer-dependent (Fig. 2B) 39K reporter
transactivation required the same regions of the IE1 poly-
peptide. N-terminal deletion mutants lacking 15 (A2-16) or
51 (A2-52) amino acids transactivated gene expression,
whereas the mutant lacking 144 (A2-145) residues did not.
Cells transfected with pA&2-16 consistently expressed 1.3- to
1.5-fold greater CAT activity than wild-type IEl-transfected
cells did, whereas pA2-52-transfected cells expressed 0.5- to
0.75-fold less activity. The results of assays conducted with
C-terminal mutants show that although deletion of 2 amino
acids (A580-582) had no effect, deletions of 25 (A557-582), 68
(A514-582), or 267 (A315-582) residues ablated transactiva-
tion function.
To determine whether loss of transactivation was either
caused by deletion of a functional domain(s) or by subopti-
mal expression and/or an inherent instability of the mutant
gene products, we analyzed IE1 proteins in transfected Sf9
cells. For this experiment, a polyclonal rabbit antiserum
raised against a bacterially expressed IE1 protein (7) was
used in a radioimmunoprecipitation assay (Fig. 3). This
antiserum specifically immunoprecipitated a protein of the
expected molecular mass (70 kDa) of IE1 in transfected cells
(Fig. 3, lane 2). This assay confirmed that, with the excep-
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FIG. 1. Schematic representation of IEl deletion mutants. (A) A partial restriction map denoting the restriction sites used in the
construction of IE1 mutants is illustrated at the top. The arrow above the map denotes the size and transcriptional direction of the IE1 mRNA.
The shaded rectangles represent IEl coding sequences. The open rectangles denote putative functional domains. The predicted molecular
masses (MW) of the deletion mutant polypeptides are shown to the right. (B) Predicted amino acid sequences of IE1 mutants at the deletion
end points. These data were derived from DNA sequence analysis. The sequences encoded by oligonucleotides inserted into the IE1 reading
frame are boxed. The numbers above the sequences denote IE1 amino acids.
tion of A2-145, the various active and inactive IE1 mutants
were expressed at approximately equivalent levels. In Fig. 2
we showed that A2-145 did not transactivate the 39K re-
porter plasmids to any measurable extent. Since we were not
able to detect this polypeptide, we could not attribute its lack
of transactivation activity to the deletion of a functional
domain.
Analysis of the autoregulatory and inhibitory activities of
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FIG. 2. Transactivation of 39K promoter-driven expression of
CAT by IE1 deletion mutants. We transfected 106 Sf9 cells with 1 ,ug
of p39CAT (without hr5) (A) or p39CATQ- (with hr5) (B) and 5 Fg
of the indicated IEl-expressing plasmids. Extracts were prepared 24
h posttransfection and analyzed for CAT activity (39CAT extracts
were undiluted, whereas 39CATQ- extracts were diluted 1:1,000).
The averages of three separate experiments are plotted as the level
of transactivation relative to wild-type IEl.
TEl deletion mutants. As mentioned above, it has been
shown that IEl stimulates expression from its own promoter
(29, 41), an activity we term autoregulation, and inhibits
expression from the IEO promoter (41). The experiment
whose results are shown in Fig. 4 was done to determine
whether the autoregulatory and inhibitory properties of IEl
could be genetically separated. A reporter plasmid (GCAT;
Fig. 4B) that expresses fused CAT gene products under the
control of both the IEO and IE1 promoters was transfected
either alone or in the presence of wild-type or mutant TEl
plasmids. We have previously shown that cotransfection of
pGCAT with pNheTEl decreases IEOCAT expression ap-
proximately 5-fold and increases TElCAT expression 5- to
10-fold (29) (Fig. 4, compare lanes 2 and 4). In addition, we
showed that an IE1 nonsense mutant (IE1AORF) has no
effect on IElCAT or IEOCAT expression (Fig. 4, compare
lanes 2 and 3).
Cotransfection with mutant TEl plasmids showed that
deletions of 15 or 51 residues from the N terminus did not
affect either autoregulatory or inhibitory activities (Fig. 4,
t c I rlt Lil;li
FIG. 3. Radioimmunoprecipitation of IEl deletion mutant gene
products. We transfected 3 x 10 Sf9 cells with 30 ,ug of the
indicated IE1 plasmids. Cells were radiolabeled, and extracts were
prepared and subsequently immunoprecipitated with rabbit poly-
clonal anti-IE1 antiserum. Immunoprecipitates were analyzed by
SDS-PAGE and autoradiography. The sizes of molecular mass
standards (in kilodaltons) are shown to the left. The asterisk denotes
the position of the A315-582 polypeptide which was expressed at a
lower level than other IE1 proteins.
lanes 5 and 6, respectively). In Fig. 2 we noted that A2-145
did not transactivate the delayed-early 39K reporter plas-
mids. In this experiment, A2-145 also failed to transactivate
IElCAT expression. However, it did inhibit IEOCAT
expression to the same extent that wild-type IE1 did (Fig. 4,
compare lanes 4 and 7), suggesting that the inhibitory and
transactivation domains of IE1 may be separable. The fact
that A2-145 inhibited IEO expression also suggests that the
lack of transactivation (Fig. 2) by this mutant is probably a
result of the loss of an activation domain and not the result
of poor expression of the mutant gene product. Lastly, the
absence of autoregulatory and inhibitory activities in mu-
tants deleted for more than 25 C-terminal residues (Fig. 4,
lanes 9, 10, and 11) suggests that this region may be essential
for these two activities.
Analysis of the DNA-binding properties of IEl deletion
mutants. Recent evidence from our laboratories has sug-
gested that IE1 may be an enhancer-binding protein (14).
The results of our functional assays with the deletion mu-
tants prompted us to determine whether the loss of transac-
tivation or inhibitory activities may result from the loss of a
DNA-binding domain. An EMSA was conducted to deter-
mine which region(s) within IE1 is essential for DNA-
binding activity. Sf9 cells were transfected with either wild-
type or mutant IE1 plasmids, and 1 day later extracts were
prepared and assayed by an EMSA with a double-stranded
DNA probe derived from a plasmid which contains the hr5
enhancer element. Extracts prepared from cells transfected
with pUC DNA (Fig. 5, lane 9) contained a nonspecific
binding activity that was not affected by the addition of
excess unlabeled probe (data not shown). Wild-type IEl and
pA580-582-transfected cells contained an hr5-specific DNA-
binding activity that resulted in the formation of at least two
complexes (lanes 1 and 2, respectively). Deletions of 25 or
B
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FIG. 4. Regulation of IE1 and IEO promoter-driven expression of
CAT by IE1 deletion mutants. (A) We cotransfected 106 Sf9 cells
with 1 .g of pGCAT and 5 pLg of the indicated IEl plasmids. Cells
were radiolabeled at 24 h postinfection for 2 h with [35S]Translabel.
Subsequently, detergent-soluble extracts were immunoprecipitated
with rabbit anti-CAT antiserum. Immunoprecipitates were analyzed
by SDS-PAGE and autoradiography. The locations of IElCAT and
IEOCAT fusion proteins are shown on the right. Asterisks denote
repressed expression of IEOCAT, and arrows indicate stimulation of
IElCAT expression. Lanes: 1, preimmune serum; 2 to 11, poly-
clonal rabbit anti-CAT serum. IE1AORF is a nonsense mutant of
IEl. (B) Illustration of the reporter plasmid pGCAT. Arrows above
the map denote the IEO (pO) and IE1 (pl) transcription initiation
sites. Intronic sequences are denoted below the map. Boxes denote
coding regions: black, IEO; stippled, IE1; open, CAT. Not drawn to
scale.
more C-terminal amino acids resulted in complete loss of
binding activity (lanes 3, 4, and 5). Deletions from the N
terminus resulted in sequentially faster-migrating com-
plexes, providing evidence that IEl is a component of the
shifted complexes.
Analysis of trans-dominant interfering mutants of IEE.
Many transcriptional regulatory proteins contain genetically
separable domains that, when expressed as independent
truncated gene products, sometimes interfere with the activ-
ity of the wild-type protein; i.e., they function as trans-
dominant repressors (13, 20, 33, 43). Of the seven IE1
mutants, four did not transactivate gene expression. To
further investigate the mechanism of TEl-mediated transac-
tivation, we first tested A557-582 (a mutant that has neither
transactivating nor DNA-binding activities) for the ability to
interfere with wild-type TEl-mediated transactivation of DE
gene expression. Sf9 cells were cotransfected with either
p39CAT or p39CATQ-, a fixed amount of pNheTEl, and
different amounts of pA557-582. Lysates were assayed for
CAT expression 1 day later. The results of this experiment
showed two very different effects on IEl-mediated transac-
tivation (Fig. 6). The expression of p39CATQ- was de-
creased up to 10-fold by increasing the amount of pA557-582
(Fig. 6A); however, expression of p39CAT remained virtu-
ally unchanged (Fig. 6B). These data suggest that A557-582
may function as a trans-dominant repressor of IE1 enhancer-
-
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FIG. 5. DNA-binding activity of IE1 deletion mutants. We trans-
fected 9 x 10' Sf9 cells with 45 pLg of either wild-type IE1, mutant
IE1, or pUC DNA. Binding lysates were prepared 24 h posttrans-
fection and incubated with a radiolabeled hr5 double-stranded DNA
probe. Binding reactions were carried out at 4'C for 20 min, and the
mixtures were subsequently analyzed by native PAGE. Arrowheads
indicate specific protein-DNA complexes.
dependent transactivation. A control experiment with a
nonsense mutant of IEl (pIElAORF) (29) in place of A557-
582 showed that it had no effect on CAT expression from
either reporter plasmid (data not shown), supporting the
hypothesis that the inhibitory effect is mediated by the
mutant IE1 gene product. These data do not rule out the
possibility that the A557-582 gene product indirectly lowered
39CATQ- expression by inhibiting pNheIE1 expression.
However, three lines of evidence argue against this hypoth-
esis. First, as shown in Fig. 4, A557-582 had no effect on
IElCAT expression in pGCAT-transfected cells (compare
lanes 2 and 9). Second, expression of an IElCAT reporter
plasmid was not affected by pA557-582 in a cotransfection
experiment (data not shown). Lastly, A557-582 had no effect
on p39CAT expression (Fig. 6B), suggesting that wild-type
IE1 levels were unaffected.
These results strongly suggest that the A557-582 gene
product directly interferes with the enhancer-dependent
transactivation function of IEl. We tested the remainder of
the IEl deletion mutants in a similar assay in an attempt to
isolate the region essential for interference activity. Since 5
,ug of pA557-582 inhibited hr-linked CAT expression by
approximately 90% (Fig. 6A), we transfected Sf9 cells with
p39CATQ-, 0.1 ,g of pNheIE1, and 5 ,ug of each IE1
mutant (Fig. 7). The results of this experiment demonstrate
that all three nontransactivating C-terminal mutants were
able to interfere with IE1 enhancer-dependent transactiva-
tion. In contrast to the other nontransactivating mutants,
A2-145 failed to demonstrate trans-dominant interference.
As expected, cells cotransfected with deletion mutants ca-
pable of transactivation expressed higher levels of CAT
activity. Lastly, none of the nontransactivating mutants
were able to interfere with the expression of p39CAT,
suggesting that interference is enhancer dependent (data not
shown).
A previous study in our laboratories demonstrated that
IEO has enhancer-dependent transactivation activity (29).
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FIG. 6. Effect of A557-582 on IEl transactivation of DE gene
expression. We cotransfected 106 Sf9 cells with 1 p.g of p39CATQ-
(A) or p39CAT (B) plus 0.1 p.g pNheIEl and the indicated amounts
of pA557-582. At 24 h posttransfection, cell lysates were prepared
and analyzed for CAT activity. The averages of the results of three
independent experiments are plotted as the amount of repression
relative to the amount of pA557-582 cotransfected. Error bars are
indicated above the columns.
Thus, we chose to investigate whether the trans-dominant
mutant A557-582 also interferes with IEO-mediated transac-
tivation. Sf9 cells were cotransfected with p39CATQ-, a
constant amount of pGC123 (an IEO-expressing plasmid),
and different amounts of pA557-582. CAT expression was
assayed 1 day after transfection (Fig. 8). Unexpectedly,
A557-582 did not interfere with IEO-mediated transactiva-
tion; conversely, increasing the amount of pA557-582 aug-
mented expression of p39CATQ-. CAT expression was
stimulated approximately two- to fourfold by increasing
amounts of pA557-582. In a control experiment in which
various amounts of pA557-582 were cotransfected with an
IEO reporter plasmid (IEOCAT), we found no significant
effect on CAT expression (data not shown).
In summary, only mutant forms of IE1 that retained the
N-terminal activation domain could trans-dominantly inter-
fere with IEl-mediated transactivation. Furthermore, these
mutants interfered only with the enhancer-dependent activa-
tion function of IE1; they had no effect on transactivation in
4 -
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i 1
0
Nhe IEl 0.1 5.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
A580-582 - - 5.0 - - - - -
A557-582 - 5.0 - -
A514-582 - - - - 5.0 -
A315-582 - - - - 5.0 -
A2-16 - 5.0
A2-52 - - - - - - - 5.0
A2-145 - - - - 5.0
gg DNA
FIG. 7. trans-dominant inhibition of DE gene expression by IEl
mutants. We cotransfected 106 Sf9 cells with 1 pug of p39CATQ-,
0.1 pLg of pNheIE1, and the indicated amounts of IEl mutants. At 24
h posttransfection, cell lysates were prepared and analyzed for CAT
activity. The average CAT activity of three separate experiments is
illustrated, with standard deviations above columns.
the absence of the hr5 enhancer. Lastly, the trans-dominant
mutant A557-582 augmented IEO-mediated transactivation.
DISCUSSION
Structural arrangement of the IEl protein. Many viruses
have genes that encode multifunctional trans-acting factors
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FIG. 8. Effect of A557-582 on IEO-mediated enhancer-dependent
transactivation. We cotransfected 106 Sf9 cells with 1 pg of
p39CATQ-, 0.5 SLg pGC123, and the indicated amounts of pA557-
582. At 24 h posttransfection, cell lysates were prepared and
analyzed for CAT activity. The averages of the results of three
independent experiments are plotted as the amount of stimulation
relative to the amount of pA557-582 cotransfected. Error bars are
indicated above the columns.
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TABLE 1. Summary of IE1 and deletion mutant activities
Amino Inhibition trans-
Protein acid Transactivation of DNA dominant
deleted' of 39K and IE EOCAT bidig interference
IEl 0 + + + NAb
A&580-582 C2 + + + NA
A557-582 C25 - - - +
A514-582 C68 - - - +
A315-582 C267 - - - +
A2-16 N15 + + + NA
A&2-52 N51 + + + NA
A&2-145 N144 - + + -
aC, carboxy; N, amino.
b NA, not applicable.
that both positively and negatively modulate gene expres-
sion. As evidenced by the functional dissections of several of
these factors, many contain multiple genetically separable
and functionally autonomous domains (13, 33, 43). We have
analyzed deletion mutants of the AcMNPV TEl regulatory
protein by using transient-expression and DNA-binding as-
says. A summary of our results is shown in Table 1. These
data suggest that IE1 has at least two distinguishable do-
mains, an N-terminal region essential for transactivation of
IE1 and 39K and a C-terminal region(s) required for DNA-
binding activity and inhibition of IEO.
Sequence comparisons between the AcMNPV and OpM
NPV TEl (AcIE1 and OpIE1) OREs have shown that they
are approximately 63% homologous (41). Interestingly, the
N-terminal one-third of the predicted ORFs shares the
smallest amount of sequence similarity (22% for amino acids
1 to 132 in OpIE1 and 1 to 150 in AcIE1). However, even
though the primary sequences have diverged, these two
regions have maintained a highly acidic profile. The N
termini of OpIE1 and AcIE1 have net charges of -13 and
-14, respectively. The C-terminal two-thirds of the IEl
ORFs share 55% overall homology, with the greatest simi-
larity (70%) between amino acids 459 to 538 in OpIE1 and
481 to 558 in AcIEL. On the basis of these structural
similarities, it has been hypothesized that the N-terminal
region of IE1 may contain an acidic activation domain and
that the more highly conserved C terminus may contain a
specificity domain.
Acidic activation region. Acidic activation domains have
been identified in a number of transactivators, including
yeast GCN4 (21) and GAL4 (2, 24) and herpes simplex virus
VP16 (43). The results presented here suggest that a 93-
amino-acid region between residues 52 and 145 may be
required for transactivation. This region contains 16 nega-
tively charged amino acids and has a net negative charge of
-12. The region between residues 1 and 52 contains an
additional 6 acidic residues which may be a component of
the activation domain. It has been shown that sequential
deletions of negatively charged amino acids within an acidic
activation domain result in diminution of activation function
(11). Consistent with that observation, A2-16 transactivated
gene expression 1.5- to 2-fold greater than A2-52 did.
IE1 is the only known baculovirus protein that transacti-
vates both minimal promoters and promoters linked to hr
enhancers. We have analyzed the effects ofIE1 deletions on
transactivation of the IE1 and DE 39K (with and without an
enhancer) promoters by transient-cotransfection assays in
uninfected cells. Our results show that the putative acidic
activation domain is required for stimulation of all three
constructs. We propose that this region of IE1 functions as a
general activation domain that may interact with a cellular
transcription factor(s). However, we do not rule out the
possibility that within this region, IEl contains separate
subdomains that are required for enhancer-independent and
-dependent transactivation.
DNA-binding region. If our working hypothesis is correct,
the N-terminal activation domain should require a second
region that confers specificity for target genes. The transient-
cotransfection assays we conducted showed consistently
that deleting 25 or more amino acids from the C terminus
resulted in loss of transactivation function. This could have
been the result of either the loss of a second activation
domain or, more consistent with our results, the deletion of
a specificity domain. This domain may confer specificity to
target genes directly (in the form of a DNA-binding domain)
or indirectly (by serving as an interface for protein-protein
interactions with factors bound to target genes). Although
the EMSA used in this study does not distinguish between
these two possibilities, it did allow us to investigate whether
IE1 was a component of the protein-DNA complex.
Prior to this study, it had been demonstrated that cells
transfected with IE1 DNA contained an hr5 enhancer-
specific DNA-binding activity (14). We believed that if the
DNA-binding domain was contained within the C-terminal
portion of the IE1 polypeptide, deletions from the N termi-
nus that do not affect the binding domain should result in
sequentially smaller IE1 gene products that form faster-
migrating complexes in an EMSA. Our results demonstrate
that IE1 forms a complex with hr5; however, we do not rule
out the possibility of additional cellular proteins bound
within these complexes.
Although sequence similarity was not found with any
other DNA-binding domain, the secondary structure of the
C-terminal amino acids from positions 485 to 582, as pre-
dicted from Chou and Fasman analysis (8), suggests that it
may fold into a helix-loop-helix (9, 44)-like DNA-binding
motif. Helix-loop-helix motifs consist of a basic stretch of
amino acids that precede two alpha helices that are sepa-
rated by a loop of variable length. Protein-protein interac-
tions mediated by the alpha helices of two helix-loop-helix-
containing proteins result in the formation of dimers. It is
believed that dimerization results in the juxtapositioning of
the basic domains of two monomers to yield a dimeric
molecule capable of binding DNA. Since there is dyad
symmetry in dimeric DNA-binding proteins, it is common
for them to bind to palindromic sequences, such as those
found in the hr5 enhancer (15). Recent evidence from our
laboratories has suggested that the IE1 gene product binds in
the form of a dimer directly to the hr5 enhancer (27;
unpublished observations). The predicted secondary struc-
ture of this region and its demonstrated requirement for
binding lead us to believe that the C terminus of IE1 contains
a DNA-binding domain.
Inhibitory domain ofIEl. It has been demonstrated by
transient-expression assays that IEl down-regulates the
expression of two other baculovirus IE genes (4, 29). We
chose to study the effect ofIEl deletions on the expression
of an IE1/IE0 reporter plasmid. Our results suggest that the
transactivating and inhibitory activities of TEl are located in
different regions of the polypeptide. The key observation
supporting this hypothesis was shown by the mutant A2-145,
which could not transactivate gene expression but down-
regulated IEO expression as efficiently as wild type TEl did.
These results also suggest that inhibition of IEO expression
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may require a functional DNA-binding domain, since dele-
tions within the binding domain ablated inhibitory activity.
These data are consistent with a previously suggested
model (29), which predicted that IE1 may play a role in E
gene modulation during viral infection. Since IEl has been
shown to regulate a number of different gene classes, we
propose that baculovirus gene regulation requires multiple
associations between different domains of IE1 and other
viral and/or cellular factors.
trans-dominant interference by IEl mutants. As noted
above, expression of a nonfunctional mutant form of a
regulatory protein may interfere with the function of the
wild-type molecule (13, 20, 33, 43). trans-dominant mutants
provide information about interactions between different
trans-acting factors and can be useful tools in the character-
ization of regulatory pathways. We found that nonfunctional
C-terminal mutants act as trans-dominant repressors of
wild-type IEl. Interestingly, they only abrogate the ability of
IEl to transactivate an enhancer-linked gene. These data
suggest that although TEl requires the same domain(s) for
both enhancer-dependent and -independent activation, there
may be a fundamental difference between these two path-
ways.
Our data also show that only nontransactivating IE1
mutants that retain the putative acidic activation domain are
able to interfere with wild-type IEL. We had initially pre-
dicted that since A2-145 was able to bind hr5, it may
interfere directly with wild-type IE1 by competing for a
binding site(s). Unexpectedly, it exhibited no interference
activity. We speculate that the acidic activation region is
involved in protein-protein interactions with an enhancer-
dependent cellular factor. Our results are consistent with the
"squelching" model of transcriptional interference (38).
According to this theory, very high concentrations of a
transactivator or a mutant form lacking a specificity domain
may sequester unbound target proteins away from cognate
genes and subsequently squelch or reduce transcription of
those genes. In our system, we believe that IE1 mutants that
are not targeted to the hr5 enhancer retain the ability to
interact with transcription factors away from the enhancer
and, in doing so, squelch p39CATQ- expression.
We had previously shown that IEO transactivates
p39CATQ- (with enhancer) but does not transactivate
p39CAT (without enhancer) (29). We speculated that if IE1
and IEO transactivate p39CATQ- via the same pathway,
A557-582 should interfere with both transactivators. Con-
trary to our expectation, A557-582 augmented transactiva-
tion of the reporter plasmid. We do not believe that A557-
582 augments IEO-mediated transactivation by enhancing
IEO levels, since it had no effect on IEOCAT expression from
the pGCAT reporter (Fig. 4, compare lanes 2 and 9).
Although a number of regulatory mechanisms are possible,
we hypothesize (i) that augmentation may occur via an
interaction between A557-582 and IEO, which results in a
more active form of IEO, or (ii) that A557-582 interacts with
a cellular factor that normally competes with IEO for a
binding site on hr5, and hence A557-582 functionally seques-
ters this factor away from the target gene.
The analyses discussed thus far do not directly demon-
strate that the various TEl mutants are correctly localized
within the transfected cell. The observed regulatory and
DNA-binding properties of IE1 lead us to assume that it is a
nuclear protein. IE1 has a predicted molecular mass of 70
kDa. This large size suggests that it may have a nuclear
localization signal. Deletion of a signal sequence may result
in improperly localized mutant polypeptides. If we assume
that trans-dominant interference is mediated by direct com-
petition for a common factor(s), proper localization would
most probably be essential. The interference assays (Fig. 7)
show that all three nontransactivating C-terminal polypep-
tides expressed interference activity, suggesting that they
are probably targeted to the same subcellular compart-
ment(s) as wild-type IEL. Lastly, although the N-terminal
mutant A2-145 did not express interference activity, it did
repress IEOCAT expression in vivo (Fig. 4, lane 7), suggest-
ing that this mutant is also localized properly.
Use of transfection assays to probe IEl function. The
transient-expression experiments described here provide a
reasonable approach to study IE1 gene function. Although
the assay has aided us in studying many of the regulatory
properties of IE1, the data are limited by the fact that they
were obtained in the absence of viral infection. Various
attempts to delete the IE1 gene from the AcMNPV genome
have failed, suggesting that it may be an essential gene
(unpublished results). As a result, extension of this type of
mutational analysis to the context of the viral genome has
not been possible. Work in our laboratories is currently
focusing on the development of inducible promoters for the
construction of conditional-lethal mutant viruses, which may
enable us to test the various IE1 mutants in the complex
environment of the infected cell.
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